Aurora Cannabis Becomes First Cannabis Firm Named to TIME Canada’s Best Companies 2026
TipRanks (Thu, 9-Jul 5:28 PM ET)
Aurora Named to TIME Canada's Best Companies 2026 List
PRNewswire (Thu, 9-Jul 4:05 PM ET)
TipRanks (Thu, 9-Jul 6:30 AM ET)
Aurora Cannabis Sets August Virtual AGM, Urges Shareholders to Vote Early
TipRanks (Wed, 8-Jul 7:57 AM ET)
PRNewswire (Wed, 8-Jul 7:15 AM ET)
PRNewswire (Thu, 11-Jun 7:05 AM ET)
Aurora Deepens its Impact for Veterans Across Canada
PRNewswire (Tue, 2-Jun 7:07 AM ET)
PRNewswire (Thu, 28-May 7:05 AM ET)
Europe's Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets
Globe Newswire (Thu, 14-May 8:45 AM ET)
Aurora Expands Medical Cannabis Reach in Germany With Daily Special Brand Launch
Market Chameleon (Thu, 18-Dec 6:14 AM ET)
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
Aurora Cannabis - Common Shares trades on the NASDAQ stock market under the symbol ACB.
As of July 13, 2026, ACB stock price declined to $2.67 with 244,350 million shares trading.
ACB has a beta of 1.50, meaning it tends to be more sensitive to market movements. ACB has a correlation of 0.14 to the broad based SPY ETF.
ACB has a market cap of $165.39 million. This is considered a Micro Cap stock.
Last quarter Aurora Cannabis - Common Shares reported $62 million in Revenue and -$.35 earnings per share. This beat revenue expectation by $7 million and missed earnings estimates by -$.28.
In the last 3 years, ACB traded as high as $11.50 and as low as $2.63.
The top ETF exchange traded funds that ACB belongs to (by Net Assets): MJ, YOLO, DFIC.
ACB has underperformed the market in the last year with a price return of -43.1% while the SPY ETF gained +21.4%. ACB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.2% and -5.7%, respectively, while the SPY returned +11.0% and +3.2%, respectively.
ACB support price is $2.64 and resistance is $2.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACB shares will trade within this expected range on the day.